These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12756203)

  • 21. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.
    Erb N; Harms DO; Janka-Schaub G
    Cancer Chemother Pharmacol; 1998; 42(4):266-72. PubMed ID: 9744770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatment.
    Bergan S; Rugstad HE; Bentdal O; Endresen L; Stokke O
    Ther Drug Monit; 1994 Feb; 16(1):13-20. PubMed ID: 8160249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay.
    Pelin M; Genova E; Fusco L; Marisat M; Hofmann U; Favretto D; Lucafò M; Taddio A; Martelossi S; Ventura A; Stocco G; Schwab M; Decorti G
    Chem Biol Interact; 2017 Sep; 275():189-195. PubMed ID: 28811125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and mechanisms of formation of S-(6-purinyl)glutathione and 6-mercaptopurine in rats given 6-chloropurine.
    Hwang IY; Elfarra AA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):41-6. PubMed ID: 8423540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.
    Hartford C; Vasquez E; Schwab M; Edick MJ; Rehg JE; Grosveld G; Pui CH; Evans WE; Relling MV
    Cancer Res; 2007 May; 67(10):4965-72. PubMed ID: 17510427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy.
    Dervieux T; Chu Y; Su Y; Pui CH; Evans WE; Relling MV
    Clin Chem; 2002 Jan; 48(1):61-8. PubMed ID: 11751539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The absorption of 6-mercaptopurine from 6-mercaptopurine riboside in rat small intestine: effect of phosphate.
    Pennington AM; Bronk JR
    Cancer Chemother Pharmacol; 1995; 36(2):136-42. PubMed ID: 7767950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease.
    Cangemi G; Barabino A; Barco S; Parodi A; Arrigo S; Melioli G
    Int J Immunopathol Pharmacol; 2012; 25(2):435-44. PubMed ID: 22697075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
    Cuffari C; Théorêt Y; Latour S; Seidman G
    Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of extracellular and intracellular thiopurines and methylthiopurines by high-performance liquid chromatography.
    Keuzenkamp-Jansen CW; De Abreu RA; Bökkerink JP; Trijbels JM
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):53-61. PubMed ID: 8590937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine lymphoma L5178Y cells resistant to purine antagonists: differences in cross-resistance to thioguanine-platinum(II) and selenoguanine-platinum(II).
    Kanzawa F; Maeda M; Sasaki T; Hoshi A; Kuretani K
    J Natl Cancer Inst; 1982 Feb; 68(2):287-91. PubMed ID: 6950160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular thiopurine nucleotides and azathioprine myelotoxicity in organ transplant patients.
    Boulieu R; Lenoir A; Bertocchi M; Mornex JF
    Br J Clin Pharmacol; 1997 Jan; 43(1):116-8. PubMed ID: 9056063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: thiopurines in inflammatory bowel disease.
    Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
    Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations.
    Lancaster DL; Patel N; Lennard L; Lilleyman JS
    Br J Clin Pharmacol; 2001 Jun; 51(6):531-9. PubMed ID: 11422012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Stocco G; Martelossi S; Arrigo S; Barabino A; Aloi M; Martinelli M; Miele E; Knafelz D; Romano C; Naviglio S; Favretto D; Cuzzoni E; Franca R; Decorti G; Ventura A
    Inflamm Bowel Dis; 2017 Apr; 23(4):628-634. PubMed ID: 28296824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and excretion of the novel bioreductive prodrug PR-104 in mice, rats, dogs, and humans.
    Gu Y; Atwell GJ; Wilson WR
    Drug Metab Dispos; 2010 Mar; 38(3):498-508. PubMed ID: 20019245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design.
    Zhang XY; Elfarra AA
    Expert Opin Drug Discov; 2018 Sep; 13(9):815-824. PubMed ID: 30101640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.
    Innocenti F; Danesi R; Bocci G; Fogli S; Di Paolo A; Del Tacca M
    Cancer Chemother Pharmacol; 1999; 43(2):133-40. PubMed ID: 9923818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.